Overview
Study information
Network: | CAVD |
Grant Affiliation: | Haynes: B cell Lineage Envelope Design from RV144 Antibodies |
Strategy: | Combo: Protein & vector vaccines |
Study Type: | Antibody Screening |
Species: | Human |
Stage: | Assays Completed |
Study Start Date: | 2015-08-28 |
Study Made Public: | 2016-07-20 |
Title
CM244 neutralization activity of memory B cell culture supernatants and recombinant mAbs from an RV305 patient
Description
CAVD 504 is an immunogenicity study to evaluate the neutralization activity of supernatants from memory B cell culture plates from a subject in RV305, the boost study to RV144.
Sign in to see full information about this study and to download study data.
Products
ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/EIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.